Entera Bio Ltd. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/05754af4-f06d-48a8-b88b-4903706003a7/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-11.5M | 2025-01-01 – 2025-12-31 | evidence 0001178913-26-001797 |
| FY 2024 | $-9.6M | 2024-01-01 – 2024-12-31 | evidence 0001178913-25-001112 |
| FY 2023 | $-8.9M | 2023-01-01 – 2023-12-31 | evidence 0001178913-24-000881 |
| FY 2022 | $-13.0M | 2022-01-01 – 2022-12-31 | evidence 0001178913-23-001272 |
| FY 2021 | $-12.2M | 2021-01-01 – 2021-12-31 | evidence 0001178913-22-000994 |
| FY 2020 | $-11.2M | 2020-01-01 – 2020-12-31 | evidence 0001178913-22-000994 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).